1. Home
  2. NAMS vs SEB Comparison

NAMS vs SEB Comparison

Compare NAMS & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • SEB
  • Stock Information
  • Founded
  • NAMS 2019
  • SEB 1918
  • Country
  • NAMS Netherlands
  • SEB United States
  • Employees
  • NAMS N/A
  • SEB N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • SEB Farming/Seeds/Milling
  • Sector
  • NAMS Health Care
  • SEB Industrials
  • Exchange
  • NAMS Nasdaq
  • SEB Nasdaq
  • Market Cap
  • NAMS 2.7B
  • SEB 2.5B
  • IPO Year
  • NAMS N/A
  • SEB N/A
  • Fundamental
  • Price
  • NAMS $27.00
  • SEB $3,930.00
  • Analyst Decision
  • NAMS Strong Buy
  • SEB
  • Analyst Count
  • NAMS 10
  • SEB 0
  • Target Price
  • NAMS $41.40
  • SEB N/A
  • AVG Volume (30 Days)
  • NAMS 872.1K
  • SEB 1.9K
  • Earning Date
  • NAMS 08-06-2025
  • SEB 10-28-2025
  • Dividend Yield
  • NAMS N/A
  • SEB 0.23%
  • EPS Growth
  • NAMS N/A
  • SEB N/A
  • EPS
  • NAMS N/A
  • SEB 143.20
  • Revenue
  • NAMS $64,006,000.00
  • SEB $9,496,000,000.00
  • Revenue This Year
  • NAMS N/A
  • SEB N/A
  • Revenue Next Year
  • NAMS N/A
  • SEB N/A
  • P/E Ratio
  • NAMS N/A
  • SEB $27.58
  • Revenue Growth
  • NAMS 762.15
  • SEB 4.70
  • 52 Week Low
  • NAMS $14.06
  • SEB $2,365.00
  • 52 Week High
  • NAMS $27.29
  • SEB $4,038.54
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.63
  • SEB 74.39
  • Support Level
  • NAMS $24.41
  • SEB $3,900.02
  • Resistance Level
  • NAMS $25.65
  • SEB $4,035.65
  • Average True Range (ATR)
  • NAMS 1.10
  • SEB 104.12
  • MACD
  • NAMS 0.05
  • SEB 11.44
  • Stochastic Oscillator
  • NAMS 98.63
  • SEB 80.67

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

Share on Social Networks: